Author

V. Moncollin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Osseni· 1 shared A. Ravel-Chapuis· 1 shared B. J. Jasmin· 1 shared I. Scionti· 1 shared L. Schaeffer· 1 shared P. Leblanc· 1 shared R. Mounier· 1 shared Y.-G. Gangloff· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. Osseni

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacological inhibition of HDAC6 downregulates TGF-β via Smad2/3 acetylation and improves dystrophin-deficient muscles.

A. Osseni, A. Ravel-Chapuis, I. Scionti, Y.-G. Gangloff, V. Moncollin, R. Mounier, P. Leblanc, B. J. Jasmin, L. Schaeffer

This study shows that inhibiting HDAC6 with tubastatin A improves dystrophin-deficient muscle by reducing fibrosis and restoring microtubules and NMJ through Smad2/3 acetylation and TGF-β signaling inhibition.

bioRxiv · Jan 21, 2022 · PreprintPhysiology